Black People : Bill Gates Funded Company Has Released Genetically Modified Mosquitoes in Florida

[Writeous1]

Here’s the story, plus some background to the story that you probably won’t see anywhere else.


Bill Gates-backed startup releases millions of genetically modified mosquitoes
https://www.entrepreneur.com/article/371072



“‘We’re pleased that the EPA and Florida state regulators have, after extensive scientific reviews, approved our demonstration trials and we look forward to continuing the collaboration with our local partners as they take up the matter.’ … The Bill & Melinda Gates Foundation has also worked with Oxitec to develop something known as a “gene drive” — a genetic modification meant to spread through multiple generations of mosquitoes to leave them sterile or unable to spread certain diseases.”
Source: Florida says ‘this is fine’ to release of genetically modified mosquitoes
https://globalnews.ca/news/7080776/genetically-modified-mosquitoes-florida/



Oxitec
https://www.gatesfoundation.org/about/committed-grants/2020/09/inv019029



Gates Foundation Awards $4.1 Million for Mosquito Engineering
https://philanthropynewsdigest.org/news/gates-foundation-awards-4.1-million-for-mosquito-engineering



Bill Gates. Military Funded Mosquito Vaccine Delivery. 2020





Zika Used to Justify Releasing Millions of Bill Gates' GM Mosquitoes in Florida





Alternative source:
FLASHBACK. ZIKA PSYNOPS TO RELEASE MILLIONS OF BILL GATES GM MODIFIED MOSQUITO'S IN FLORIDA (MIRROR






Mosquito Flying Angel of Death 2021 - A Bill Gates Creation...

 

[Writeous1]

And if you want undeniable proof that the Zika scare was a hoax, here you go. This first video starts off a little slow, but hang in there. And if you need sources, it’s all there.



Interview 1134 – Jon Rappoport Dissects the Zika Hype
https://www.corbettreport.com/interview-1134-jon-rappoport-dissects-the-zika-hype/





Zika Fear Falters as False Flag Fraud Fizzles
https://www.corbettreport.com/zika-fear-falters-as-false-flag-fraud-fizzles/






“The U.S. Department of Health and Human Services has shifted $81 million in funds from other projects to continue work on developing vaccines to fight Zika in the absence of any funding from U.S. lawmakers. … At a press briefing in Washington, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he needs $33 million to prepare to move the first potential Zika vaccine to the second phase of human clinical trials. … Drugs frequently fail to realize the promise they show in early trials. ‘We still need about $196 million more,’ he said. Fauci said the health secretary’s action was essentially one of desperation given the failure of Congress to authorize additional funding. Taking money from other research programs ‘is extremely damaging to the biomedical research enterprise,’ he said. ‘We’re taking money away from cancer, diabetes, all those things.’ Dr. LaMar Hasbrouck, executive director of the National Association of County and City Health Officials, said at the briefing that local health authorities are similarly siphoning off money from other programs.”
Source: U.S. government shifts $81 million to Zika vaccine research
(August 11, 2016)
https://www.reuters.com/article/us-health-zika-vaccines-idUSKCN10M20K



“Section 564 of the Federal Food, Drug, and Cosmetic (FD&C) Act permits the FDA to authorize the use of an unapproved medical product or an unapproved use of an approved medical product for certain emergency circumstances. The FDA may issue an EUA in response to emergencies involving chemical, biological, radiological and nuclear (CBRN) agents, including emerging infectious disease threats such as COVID-19. Other measures similar to but separate and distinct from EUAs are found in other provisions of the FD&C Act. For example, Section 564A of the FD&C Act establishes streamlined mechanisms to facilitate preparedness and response activities involving certain FDA-approved medical countermeasures without the FDA issuing an EUA. Examples of streamlined activities include empowering the FDA to extend expiration dates of eligible products, permitting the FDA to waive current good manufacturing practice requirements, and allowing emergency dispensing of medical countermeasures during an actual emergency event without requiring an individual prescription for each patient if permitted by state law in the state where such dispensing occurs or if in accordance with an order issued by the FDA.[3] … The two EUA declarations made by Azar reference COVID-19, which is causing serious and life-threatening disease worldwide. Drugs or medical devices that may be considered for an EUA are those that ‘may be effective’ to prevent, diagnose, or treat serious or life-threatening diseases or conditions that can be caused by a CBRN agent identified in the HHS secretary’s EUA declaration.[5] The ‘may be effective’ standard is a lower bar than the standard used for traditional FDA approval and is based on a totality of scientific evidence available. … Both unapproved products and approved products intended for unapproved uses are eligible for EUAs. … Past EUAs granted for historical emergencies include diagnostic tests for Zika, mass dispensing of doxycycline for post-exposure prophylaxis involving anthrax, and diagnostic tests for Ebola.”
Source: FDA Emergency Use Authorizations (EUAs): Cutting Regulatory Red Tape for COVID-19
https://www.bakerlaw.com/alerts/fda...euas-cutting-regulatory-red-tape-for-covid-19